Company Filing History:
Years Active: 1993-2001
Title: Innovations by John Jelesko: Pioneering Receptors for Immune Complexes
Introduction
John Jelesko is an esteemed inventor based in Seattle, Washington. With a total of two patents to his name, he has made significant contributions in the field of immunology. His innovative work focuses on the development of receptors for immune complexes, enhancing the accuracy and effectiveness of diagnostic methods.
Latest Patents
John Jelesko's recent patents revolve around receptors that are antibodies exhibiting a superior binding affinity for immune complexes comprised of monoepitopic antigens and their corresponding antibodies. One of the focal points of his patents includes the creation of antibodies that significantly improve the method for determining monoepitopic antigens in biological samples. The patented methods involve forming an immune sandwich complex, which facilitates the accurate detection of these antigens. This method uses a first monoclonal antibody that binds to the monoepitopic antigen, along with a second monoclonal antibody, which is one of Jelesko's innovations. Additionally, his patents cover compositions and kits designed for conducting assays relating to these immune receptors, thereby extending their practical application in laboratories.
Career Highlights
Throughout his career, John Jelesko has gained valuable experience from his tenure at notable companies, including Syntex (U.S.A.) Inc. and Dade Behring Marburg GmbH. His roles at these organizations have allowed him to cultivate his expertise and drive innovative research in immunology and biotechnology.
Collaborations
Jelesko has worked alongside esteemed colleagues such as Edwin F. Ullman and Marcel R. Pirio. His collaborations with these professionals reflect his dedication to advancing scientific knowledge through teamwork and shared expertise.
Conclusion
John Jelesko continues to be a prominent figure in the field of immunology, with his patents showcasing groundbreaking approaches to immune detection. His work on receptors for immune complexes holds the potential to significantly enhance diagnostic capabilities in medical laboratories, paving the way for future innovations in healthcare.